Close Menu

NEW YORK – Elypta said on Thursday it has raised €6.1 million ($6.8 million) in a late seed funding round. The Stockholm-based company said it will use the funds to develop its metabolism-based liquid biopsy platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.